Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design.
Iuliana VaxmanShaji K KumarFrancis K BuadiM Q LacyDavid DingliY HwaA FonderM HobbsS HaymanTaxiarchis V KourelisR WarsameEli MuchtarNelson R LeungP KapoorM GroganRonald S GoY LinW GonsalvesMustaqeem A SiddiquiR A KyleS V RajkumarMorie A GertzAngela DispenzieriPublished in: Leukemia (2021)